This document summarizes a venture that produces a novel nutraceutical beverage from banana using enzyme technology. The beverage contains bioactives that deactivate intestinal pathogens and glycocores that strengthen the intestinal walls. It aims to prevent gut disorders through a preventative health approach. The venture is currently undergoing prototype testing and seeking initial marketing contacts. It has obtained funding from the Department of Biotechnology and plans to commercialize the product globally as the first of its kind to target gut health in this manner.
Phytochemical Composition and Nutritional Properties of Non-Diary Probiotic B...CrimsonpublishersNTNF
This document summarizes a research study on the phytochemical composition and nutritional properties of non-dairy probiotic beverages. Key findings include:
- Probiotic beverages were produced using extracts of various fruits, vegetables, and herbs. Phytochemical analysis found the presence of cardiac glycosides, alkaloids, flavonoids, and reducing sugars but not steroids, phenols, tannins, terpenoids, glycosides, or saponins.
- Proximate analysis found the beverages had high moisture content (over 96%), low levels of fat and carbohydrates, and no crude fiber. Crude protein and ash levels varied between samples.
- The
Functional foods are foods that provide health benefits beyond basic nutrition for the prevention or treatment of diseases. They are similar in appearance to conventional foods and are consumed as part of a regular diet. Functional foods contain biologically-active compounds that provide clinically proven health benefits when consumed in effective and non-toxic amounts. Interest in functional foods is growing due to an aging population, rising healthcare costs, and advances in science. The global market for functional foods is estimated to reach $2.5 billion by 2020.
Application of biotechnology in functional foodsJohnson Mwove
Functional foods are foods that contain components that provide health benefits beyond basic nutrition. Biotechnology can be used to develop functional foods through genetic modification or by increasing bioactive compounds. The document discusses how biotechnology has been applied to functional foods including producing "golden rice" with increased beta-carotene and iron, "BioCassava" with increased vitamins and minerals, and probiotic foods. It also discusses using enzymes and fermentation to modify starches and proteins in foods. The conclusion is that genetic engineering can help deliver nutrients to address health problems, though more safety research is still needed.
Functional foods are foods that provide health benefits beyond basic nutrition. Japan was the first country to recognize functional foods in 1991 through its FOSHU system. The FSSAI in India issued regulations for functional foods and other products in 2016. Regulations vary between countries but generally classify claims and require scientific evidence to substantiate health claims. Claims are also regulated differently, from general nutrition claims to disease risk reduction claims. Human studies are often needed to approve claims. The FOSHU system and Codex Alimentarius provide frameworks that many countries follow for their own regulations on functional foods and health claims.
Legal and regulatory aspects of functional and medical foodsAxon Lawyers
1. The document discusses the legal frameworks governing functional foods and medical foods in the EU and Netherlands. It outlines key definitions and requirements for these categories of foods.
2. For medical foods, regulations establish composition standards and require they are only used under medical supervision. Claims on medical foods are limited mainly to general nutrition functions. Food information regulations also apply.
3. Functional foods have no single regulatory definition and are subject to various laws depending on their attributes. Nutrition and health claims may be used if scientific evidence and conditions of use are met. The food information regulation introduces new labeling requirements.
1) Regulations/guidelines relating to functional foods in Japan began in 1991 with the establishment of Foods for Specified Health Uses (FOSHU).
2) FOSHU were later joined by Foods with Nutrient Function Claims in 2001, which allowed for pre-approved claims about specific nutrient functions.
3) The FOSHU system was amended in 2005 to allow for standardized claims for certain fibers and oligosaccharides without clinical studies, as well as qualified and disease risk reduction claims with suggestive evidence rather than conclusive proof of efficacy.
Marketing and regulatory issues for functional food by sakshiSakshi Thakur
This document discusses marketing and regulatory issues for functional foods and nutraceuticals in India. It provides an introduction to functional foods and nutraceuticals, and outlines some of the key components and potential health benefits. It then discusses the history of food regulation in India, focusing on recent legislation like the Food Safety and Standard Act of 2006. This act aims to consolidate various food laws and establish a single authority to regulate the food sector. However, more regulation is still needed for functional foods and nutraceuticals. The document also discusses licensing requirements, health claims, positioning benefits, and the growing Indian market for these products.
Food biotechnology employs modern genetic techniques to enhance beneficial traits in plants, animals, and microorganisms for food production. It allows adding or extracting select genes to achieve desired traits like increased yields, nutrition, and resistance to pests and disease. Studies show that properly regulated food biotechnology is safe and can help address issues like global hunger by producing more food on less land. However, some argue unintended effects need further review and consumers support labeling of biotech ingredients. Overall, experts agree food biotechnology has potential benefits but continuous research and oversight is important.
Phytochemical Composition and Nutritional Properties of Non-Diary Probiotic B...CrimsonpublishersNTNF
This document summarizes a research study on the phytochemical composition and nutritional properties of non-dairy probiotic beverages. Key findings include:
- Probiotic beverages were produced using extracts of various fruits, vegetables, and herbs. Phytochemical analysis found the presence of cardiac glycosides, alkaloids, flavonoids, and reducing sugars but not steroids, phenols, tannins, terpenoids, glycosides, or saponins.
- Proximate analysis found the beverages had high moisture content (over 96%), low levels of fat and carbohydrates, and no crude fiber. Crude protein and ash levels varied between samples.
- The
Functional foods are foods that provide health benefits beyond basic nutrition for the prevention or treatment of diseases. They are similar in appearance to conventional foods and are consumed as part of a regular diet. Functional foods contain biologically-active compounds that provide clinically proven health benefits when consumed in effective and non-toxic amounts. Interest in functional foods is growing due to an aging population, rising healthcare costs, and advances in science. The global market for functional foods is estimated to reach $2.5 billion by 2020.
Application of biotechnology in functional foodsJohnson Mwove
Functional foods are foods that contain components that provide health benefits beyond basic nutrition. Biotechnology can be used to develop functional foods through genetic modification or by increasing bioactive compounds. The document discusses how biotechnology has been applied to functional foods including producing "golden rice" with increased beta-carotene and iron, "BioCassava" with increased vitamins and minerals, and probiotic foods. It also discusses using enzymes and fermentation to modify starches and proteins in foods. The conclusion is that genetic engineering can help deliver nutrients to address health problems, though more safety research is still needed.
Functional foods are foods that provide health benefits beyond basic nutrition. Japan was the first country to recognize functional foods in 1991 through its FOSHU system. The FSSAI in India issued regulations for functional foods and other products in 2016. Regulations vary between countries but generally classify claims and require scientific evidence to substantiate health claims. Claims are also regulated differently, from general nutrition claims to disease risk reduction claims. Human studies are often needed to approve claims. The FOSHU system and Codex Alimentarius provide frameworks that many countries follow for their own regulations on functional foods and health claims.
Legal and regulatory aspects of functional and medical foodsAxon Lawyers
1. The document discusses the legal frameworks governing functional foods and medical foods in the EU and Netherlands. It outlines key definitions and requirements for these categories of foods.
2. For medical foods, regulations establish composition standards and require they are only used under medical supervision. Claims on medical foods are limited mainly to general nutrition functions. Food information regulations also apply.
3. Functional foods have no single regulatory definition and are subject to various laws depending on their attributes. Nutrition and health claims may be used if scientific evidence and conditions of use are met. The food information regulation introduces new labeling requirements.
1) Regulations/guidelines relating to functional foods in Japan began in 1991 with the establishment of Foods for Specified Health Uses (FOSHU).
2) FOSHU were later joined by Foods with Nutrient Function Claims in 2001, which allowed for pre-approved claims about specific nutrient functions.
3) The FOSHU system was amended in 2005 to allow for standardized claims for certain fibers and oligosaccharides without clinical studies, as well as qualified and disease risk reduction claims with suggestive evidence rather than conclusive proof of efficacy.
Marketing and regulatory issues for functional food by sakshiSakshi Thakur
This document discusses marketing and regulatory issues for functional foods and nutraceuticals in India. It provides an introduction to functional foods and nutraceuticals, and outlines some of the key components and potential health benefits. It then discusses the history of food regulation in India, focusing on recent legislation like the Food Safety and Standard Act of 2006. This act aims to consolidate various food laws and establish a single authority to regulate the food sector. However, more regulation is still needed for functional foods and nutraceuticals. The document also discusses licensing requirements, health claims, positioning benefits, and the growing Indian market for these products.
Food biotechnology employs modern genetic techniques to enhance beneficial traits in plants, animals, and microorganisms for food production. It allows adding or extracting select genes to achieve desired traits like increased yields, nutrition, and resistance to pests and disease. Studies show that properly regulated food biotechnology is safe and can help address issues like global hunger by producing more food on less land. However, some argue unintended effects need further review and consumers support labeling of biotech ingredients. Overall, experts agree food biotechnology has potential benefits but continuous research and oversight is important.
Probiotics are live microorganisms that provide health benefits when consumed. Common probiotic strains include Lactobacillus and Bifidobacteria. Probiotics have shown benefits for digestive health such as controlling diarrhea, stomach upset, and constipation. Evidence also suggests probiotics may help control urinary tract infections, candidiasis, and help replace beneficial microbes after antibiotic use. However, more research is still needed to determine the specific health benefits of different probiotic strains. Probiotics are generally considered safe but can potentially cause infections in immune compromised individuals.
REGULATORY ASPECTS OF FOOD & NUTRACEUTICALS A GLOBALKapilKumar198
This presentation contains detailed information about the regulatory aspects of food and nutraceuticals a global prospective, which includes WHO guidelines on nutrition and NSF International.
Five yogurt brands were evaluated through culture analysis and quantification of bacterial colonies. The study found discrepancies between manufacturer labels and actual bacterial contents. Yoplait labels stated only L. acidophilus but cultures also identified S. thermophilus and L. bulgaricus. Dannon did not list any bacteria found through analysis. Colonies per gram were lower than the National Yogurt Association's 100 million standard, at 1.38 million for Yoplait and 1.43 million for Activia. The results suggest yogurt labels may not accurately reflect bacterial contents.
“FUNCTIONAL FOODS: CLAIMS AND LABELING” -- AN OVERVIEW OF THE LAWMichael Swit
Presentation to the Regulatory Affairs Professionals Society (RAPS) & University of Southern California School of Pharmacy conference on Dietary Supplements & Supplemental Foods." November 2000, Pasadena, CA., covering:
♦ What is a Functional Food
♦ Claims under Nutritional Labeling and Educations Act (NLEA)
♦ FDAMA Claims
♦ FTC Advertising Regulation
This document discusses regulations and guidelines relating to functional foods in Southeast Asia. It provides an overview of the International Life Sciences Institute's (ILSI) work on functional foods and the status of nutrition and health claims in countries in the Southeast Asia region. It notes there are generally no harmonized regulations on claims across SEA countries. It also compares claim requirements to those in the United States, and outlines some of the challenges and opportunities around functional foods regulations in Southeast Asia.
Achieve the bioproduction of microalgae and evaluate of bioactivity of compounds, with inmuno-stimulating activity, suitable for food fortification and the development of new food formats of specific functionality of strengthening the immune system
PPT ON NUTRACEUTICAL AND THEIR LABELINGGOVIND YADAV
The document provides information on regulatory requirements for nutraceutical labeling in India, Japan, and Canada. It discusses the following key points:
- Nutraceutical labels in India must include ingredients, purpose, maximum retail price and other mandatory information as regulated by the Food Safety and Standards Authority of India.
- Japan has stringent labeling systems that require providing detailed information on nutrition, ingredients, and health claims.
- Canada regulates nutraceuticals under the Natural Health Products Directorate and labels must meet requirements including a product license number and evidence-based safety and efficacy claims.
- Regulations differ across countries but generally aim to standardize labeling practices to inform consumers.
Nutraceuticals: The Front Line of the Battle for Consumer HealthSemalytix
Consumer healthcare has become competitive as pharmaceutical and consumer goods firms vie for growth in nutraceuticals. Nutraceuticals present opportunities for preventative and management solutions for common health issues currently only addressed by pharmaceuticals. However, growth is modest due to misunderstandings about nutrition's impact on health and a fragmented regulatory environment. Consumer goods firms currently lead in nutraceutical sales but face challenges in scientific innovation, evidence, and medical channels that pharmaceutical firms have advantages in.
By Jun Tamagawa, Director from the Office of Health Policies on Newly Developed Foods, Department of Food Safety, Pharmaceutical and Food Safety Bureau, Ministry of Health, Labour and Welfare
Biotechnology in the Philippines - NASTJoener Vidal
The document provides an overview of biotechnology in the Philippines, including:
- Key policies and milestones in biotechnology starting in 1979 with the establishment of the National Institute of Biotechnology.
- Current areas of biotechnology research and development in the Philippines including improved crops, animal health, foods and feeds, industrial products, and genomics.
- Examples of transgenic crop field testing including papaya, rice, and Bt corn along with adoption of foreign biotech crops.
- Ongoing genome sequencing and diagnostic work at universities including targeting diseases like tuberculosis and malaria.
- Agriculture programs at the Philippine Genome Center focused on enhancing productivity through genomics.
This document discusses various post-harvest techniques to extend the shelf life of fruits, including alternative methods, genetic modification, and risks of GM crops. It describes edible coatings using hydrocolloids, lipids, and composites to act as barriers and reduce moisture loss and microbial growth in fruits. Ethylene inhibitors like AVG, silver ions, and 1-MCP are discussed as ways to delay fruit ripening. The document also outlines potential advantages and ecological risks of genetically modified crops, including increasing yields and reducing pesticide use but also possible risks of allergies, lower biodiversity, and antibiotic resistance.
The document discusses current regulatory perspectives on genetically modified (GM) food in Indonesia. It provides an overview of the global situation and regulations regarding GM foods. It then outlines Indonesia's policies, including that GM foods must undergo pre-market biosafety assessment and be labeled if they contain GM materials above a certain threshold. The key laws and regulations governing GM foods in Indonesia are also summarized. [END SUMMARY]
Biotechnological applications in Food ProcessingAbdul Rehman
Deals with various applications of biotechnology in Food processing includes genetically modified food and the concept of metabolic engineering as a novel technique.
161201 foods with function claims system in japanneerjayakult
1) The document discusses Japan's new "Foods with Function Claims" system which allows foods to make certain health claims after notifying authorities and providing evidence of safety and effectiveness.
2) It provides an overview of international regulations on health claims in the EU, US, and Japan and compares Japan's new system to regulations for dietary supplements in the US.
3) Statistics are given on the number and types of health claims made for foods under the new Japanese system between 2015-2016, including many claims related to digestion, fat reduction, and cholesterol.
This document summarizes recent research on phytochemicals. It discusses studies that examined the effects of thermal treatments and cooking methods on phytochemical content in berries and vegetables. Other studies investigated the phytochemical profiles and antioxidant activities of black rice, hot peppers, and lettuce grown with abscisic acid. The document concludes that phytochemical content is dependent on many factors and more research is needed to understand actual health benefits.
In tech fermentation-processes_using_lactic_acid_bacteria_producing_bacterioc...Beneficial Biologics
This document discusses the use of lactic acid bacteria and bacteriocins for food preservation and improving food properties. Lactic acid bacteria play a key role in food fermentation by contributing to sensory properties and microbiological safety. Bacteriocins produced by lactic acid bacteria are antimicrobial peptides that can enhance food safety. Recent interest has grown in bacteriocin-like inhibitory substances from lactic acid bacteria due to their potential as natural antimicrobials in foods. However, literature is lacking on using bacteriocins or bacteriocin-producing strains to preserve and improve the properties of vegetable and fruit products.
“Biotechnology’s Contributions to Increased Philippine Food Security”, presented by Randy Hautea, Global Coordinator, ISAAA at the ReSAKSS-Asia Conference, Nov 14-16, 2011, in Kathmandu, Nepal.
This document discusses safety considerations regarding probiotics. It notes that safety assessments must take into account the microbe used, administration method, exposure level, and user health status. While few adverse events have been reported, they primarily occur in individuals with underlying conditions. Further research is needed on probiotic use in at-risk populations like immunocompromised individuals. International regulatory frameworks are needed to address probiotic efficacy, safety, labeling, and claims.
The document summarizes the history and development of biotechnology in the Philippines from 1979 to 2012. It discusses key events like the establishment of regulatory bodies and guidelines, approval of crops like Bt corn and cotton, and increasing adoption of biotech crops. The Philippines was one of the early adopters of agricultural biotechnology in Southeast Asia and has served as a model for regulatory systems. Area planted to biotech crops like Bt corn has grown significantly in recent years.
This document discusses the roles of O-linked β-N-acetylglucosamine (O-GlcNAc) in physiology and the analytical challenges of studying it. O-GlcNAc is a post-translational modification found on nuclear and cytosolic proteins that is involved in nutrient sensing and the regulation of many cellular processes. It has extensive crosstalk with phosphorylation and over 3000 protein sites have been mapped to date. Increased global O-GlcNAcylation, even over just 2.5 hours, affects the occupancy of nearly every phosphorylated site that is actively cycling. Many kinases are also regulated by O-GlcNAcylation, with over 40 synaptic kinases identified as being O-
1) The document examines how elevating O-GlcNAc levels through OGA inhibition or increasing OGT substrate availability affects mitochondrial function.
2) Experiments found that elevated O-GlcNAc levels decreased mitochondrial respiration and ATP production, while reducing reactive oxygen species levels.
3) Pathway analysis predicted that the NRF2-mediated oxidative stress response, a key regulator of antioxidants, was downregulated with elevated O-GlcNAc. Protein expression of antioxidant genes regulated by NRF2, such as TXNRD1, were also reduced.
4) Together, the results demonstrate that prolonged alterations to cellular O-GlcNAc homeostasis impact mitochondrial function and metabolism.
Probiotics are live microorganisms that provide health benefits when consumed. Common probiotic strains include Lactobacillus and Bifidobacteria. Probiotics have shown benefits for digestive health such as controlling diarrhea, stomach upset, and constipation. Evidence also suggests probiotics may help control urinary tract infections, candidiasis, and help replace beneficial microbes after antibiotic use. However, more research is still needed to determine the specific health benefits of different probiotic strains. Probiotics are generally considered safe but can potentially cause infections in immune compromised individuals.
REGULATORY ASPECTS OF FOOD & NUTRACEUTICALS A GLOBALKapilKumar198
This presentation contains detailed information about the regulatory aspects of food and nutraceuticals a global prospective, which includes WHO guidelines on nutrition and NSF International.
Five yogurt brands were evaluated through culture analysis and quantification of bacterial colonies. The study found discrepancies between manufacturer labels and actual bacterial contents. Yoplait labels stated only L. acidophilus but cultures also identified S. thermophilus and L. bulgaricus. Dannon did not list any bacteria found through analysis. Colonies per gram were lower than the National Yogurt Association's 100 million standard, at 1.38 million for Yoplait and 1.43 million for Activia. The results suggest yogurt labels may not accurately reflect bacterial contents.
“FUNCTIONAL FOODS: CLAIMS AND LABELING” -- AN OVERVIEW OF THE LAWMichael Swit
Presentation to the Regulatory Affairs Professionals Society (RAPS) & University of Southern California School of Pharmacy conference on Dietary Supplements & Supplemental Foods." November 2000, Pasadena, CA., covering:
♦ What is a Functional Food
♦ Claims under Nutritional Labeling and Educations Act (NLEA)
♦ FDAMA Claims
♦ FTC Advertising Regulation
This document discusses regulations and guidelines relating to functional foods in Southeast Asia. It provides an overview of the International Life Sciences Institute's (ILSI) work on functional foods and the status of nutrition and health claims in countries in the Southeast Asia region. It notes there are generally no harmonized regulations on claims across SEA countries. It also compares claim requirements to those in the United States, and outlines some of the challenges and opportunities around functional foods regulations in Southeast Asia.
Achieve the bioproduction of microalgae and evaluate of bioactivity of compounds, with inmuno-stimulating activity, suitable for food fortification and the development of new food formats of specific functionality of strengthening the immune system
PPT ON NUTRACEUTICAL AND THEIR LABELINGGOVIND YADAV
The document provides information on regulatory requirements for nutraceutical labeling in India, Japan, and Canada. It discusses the following key points:
- Nutraceutical labels in India must include ingredients, purpose, maximum retail price and other mandatory information as regulated by the Food Safety and Standards Authority of India.
- Japan has stringent labeling systems that require providing detailed information on nutrition, ingredients, and health claims.
- Canada regulates nutraceuticals under the Natural Health Products Directorate and labels must meet requirements including a product license number and evidence-based safety and efficacy claims.
- Regulations differ across countries but generally aim to standardize labeling practices to inform consumers.
Nutraceuticals: The Front Line of the Battle for Consumer HealthSemalytix
Consumer healthcare has become competitive as pharmaceutical and consumer goods firms vie for growth in nutraceuticals. Nutraceuticals present opportunities for preventative and management solutions for common health issues currently only addressed by pharmaceuticals. However, growth is modest due to misunderstandings about nutrition's impact on health and a fragmented regulatory environment. Consumer goods firms currently lead in nutraceutical sales but face challenges in scientific innovation, evidence, and medical channels that pharmaceutical firms have advantages in.
By Jun Tamagawa, Director from the Office of Health Policies on Newly Developed Foods, Department of Food Safety, Pharmaceutical and Food Safety Bureau, Ministry of Health, Labour and Welfare
Biotechnology in the Philippines - NASTJoener Vidal
The document provides an overview of biotechnology in the Philippines, including:
- Key policies and milestones in biotechnology starting in 1979 with the establishment of the National Institute of Biotechnology.
- Current areas of biotechnology research and development in the Philippines including improved crops, animal health, foods and feeds, industrial products, and genomics.
- Examples of transgenic crop field testing including papaya, rice, and Bt corn along with adoption of foreign biotech crops.
- Ongoing genome sequencing and diagnostic work at universities including targeting diseases like tuberculosis and malaria.
- Agriculture programs at the Philippine Genome Center focused on enhancing productivity through genomics.
This document discusses various post-harvest techniques to extend the shelf life of fruits, including alternative methods, genetic modification, and risks of GM crops. It describes edible coatings using hydrocolloids, lipids, and composites to act as barriers and reduce moisture loss and microbial growth in fruits. Ethylene inhibitors like AVG, silver ions, and 1-MCP are discussed as ways to delay fruit ripening. The document also outlines potential advantages and ecological risks of genetically modified crops, including increasing yields and reducing pesticide use but also possible risks of allergies, lower biodiversity, and antibiotic resistance.
The document discusses current regulatory perspectives on genetically modified (GM) food in Indonesia. It provides an overview of the global situation and regulations regarding GM foods. It then outlines Indonesia's policies, including that GM foods must undergo pre-market biosafety assessment and be labeled if they contain GM materials above a certain threshold. The key laws and regulations governing GM foods in Indonesia are also summarized. [END SUMMARY]
Biotechnological applications in Food ProcessingAbdul Rehman
Deals with various applications of biotechnology in Food processing includes genetically modified food and the concept of metabolic engineering as a novel technique.
161201 foods with function claims system in japanneerjayakult
1) The document discusses Japan's new "Foods with Function Claims" system which allows foods to make certain health claims after notifying authorities and providing evidence of safety and effectiveness.
2) It provides an overview of international regulations on health claims in the EU, US, and Japan and compares Japan's new system to regulations for dietary supplements in the US.
3) Statistics are given on the number and types of health claims made for foods under the new Japanese system between 2015-2016, including many claims related to digestion, fat reduction, and cholesterol.
This document summarizes recent research on phytochemicals. It discusses studies that examined the effects of thermal treatments and cooking methods on phytochemical content in berries and vegetables. Other studies investigated the phytochemical profiles and antioxidant activities of black rice, hot peppers, and lettuce grown with abscisic acid. The document concludes that phytochemical content is dependent on many factors and more research is needed to understand actual health benefits.
In tech fermentation-processes_using_lactic_acid_bacteria_producing_bacterioc...Beneficial Biologics
This document discusses the use of lactic acid bacteria and bacteriocins for food preservation and improving food properties. Lactic acid bacteria play a key role in food fermentation by contributing to sensory properties and microbiological safety. Bacteriocins produced by lactic acid bacteria are antimicrobial peptides that can enhance food safety. Recent interest has grown in bacteriocin-like inhibitory substances from lactic acid bacteria due to their potential as natural antimicrobials in foods. However, literature is lacking on using bacteriocins or bacteriocin-producing strains to preserve and improve the properties of vegetable and fruit products.
“Biotechnology’s Contributions to Increased Philippine Food Security”, presented by Randy Hautea, Global Coordinator, ISAAA at the ReSAKSS-Asia Conference, Nov 14-16, 2011, in Kathmandu, Nepal.
This document discusses safety considerations regarding probiotics. It notes that safety assessments must take into account the microbe used, administration method, exposure level, and user health status. While few adverse events have been reported, they primarily occur in individuals with underlying conditions. Further research is needed on probiotic use in at-risk populations like immunocompromised individuals. International regulatory frameworks are needed to address probiotic efficacy, safety, labeling, and claims.
The document summarizes the history and development of biotechnology in the Philippines from 1979 to 2012. It discusses key events like the establishment of regulatory bodies and guidelines, approval of crops like Bt corn and cotton, and increasing adoption of biotech crops. The Philippines was one of the early adopters of agricultural biotechnology in Southeast Asia and has served as a model for regulatory systems. Area planted to biotech crops like Bt corn has grown significantly in recent years.
This document discusses the roles of O-linked β-N-acetylglucosamine (O-GlcNAc) in physiology and the analytical challenges of studying it. O-GlcNAc is a post-translational modification found on nuclear and cytosolic proteins that is involved in nutrient sensing and the regulation of many cellular processes. It has extensive crosstalk with phosphorylation and over 3000 protein sites have been mapped to date. Increased global O-GlcNAcylation, even over just 2.5 hours, affects the occupancy of nearly every phosphorylated site that is actively cycling. Many kinases are also regulated by O-GlcNAcylation, with over 40 synaptic kinases identified as being O-
1) The document examines how elevating O-GlcNAc levels through OGA inhibition or increasing OGT substrate availability affects mitochondrial function.
2) Experiments found that elevated O-GlcNAc levels decreased mitochondrial respiration and ATP production, while reducing reactive oxygen species levels.
3) Pathway analysis predicted that the NRF2-mediated oxidative stress response, a key regulator of antioxidants, was downregulated with elevated O-GlcNAc. Protein expression of antioxidant genes regulated by NRF2, such as TXNRD1, were also reduced.
4) Together, the results demonstrate that prolonged alterations to cellular O-GlcNAc homeostasis impact mitochondrial function and metabolism.
http://inarocket.com
Learn BEM fundamentals as fast as possible. What is BEM (Block, element, modifier), BEM syntax, how it works with a real example, etc.
How to Build a Dynamic Social Media PlanPost Planner
Stop guessing and wasting your time on networks and strategies that don’t work!
Join Rebekah Radice and Katie Lance to learn how to optimize your social networks, the best kept secrets for hot content, top time management tools, and much more!
Watch the replay here: bit.ly/socialmedia-plan
Lightning Talk #9: How UX and Data Storytelling Can Shape Policy by Mika Aldabaux singapore
How can we take UX and Data Storytelling out of the tech context and use them to change the way government behaves?
Showcasing the truth is the highest goal of data storytelling. Because the design of a chart can affect the interpretation of data in a major way, one must wield visual tools with care and deliberation. Using quantitative facts to evoke an emotional response is best achieved with the combination of UX and data storytelling.
The document discusses how personalization and dynamic content are becoming increasingly important on websites. It notes that 52% of marketers see content personalization as critical and 75% of consumers like it when brands personalize their content. However, personalization can create issues for search engine optimization as dynamic URLs and content are more difficult for search engines to index than static pages. The document provides tips for SEOs to help address these personalization and SEO challenges, such as using static URLs when possible and submitting accurate sitemaps.
This document summarizes a study of CEO succession events among the largest 100 U.S. corporations between 2005-2015. The study analyzed executives who were passed over for the CEO role ("succession losers") and their subsequent careers. It found that 74% of passed over executives left their companies, with 30% eventually becoming CEOs elsewhere. However, companies led by succession losers saw average stock price declines of 13% over 3 years, compared to gains for companies whose CEO selections remained unchanged. The findings suggest that boards generally identify the most qualified CEO candidates, though differences between internal and external hires complicate comparisons.
Probiotics with documented health benefits give
dairies a huge opportunity to stand out on the yogurt
market in Southeast Asia. But there are challenges to
overcome, writes DR. ANDERS HENRIKSSON.
The pain point of functional beverage formulators in the UKfoodresearch
The functional beverage formulators in the UK deals with a variety of challenges in pleasing their clients the blog aims at novel solution for such issues.
This document discusses microalgae as functional food ingredients. It begins with an overview of AINIA, a technology center with expertise in bioproduction. Section 2 discusses trends in using microalgae in new food products and the most commonly used species. Section 3 outlines requirements for developing commercial microalgae products, including legal, commercial, functional, and technological aspects. Section 4 describes prototype development, including designing healthy foods, characterization studies, and in vitro digestion models to evaluate bioavailability and functionality. The document concludes by discussing other potential markets for microalgae such as agriculture, biomedical, and cosmetics applications.
Happy to share this month’s edition of Nutrify Today magazine. This is no ordinary magazine that scraps internet data and presents to you some news. We hardly carry any news.
Our team carefully screens innovators from across the world and feature innovation of the month that is ready for goto market. Our technical team deeply analyzes latest patents being filed across the world on nutraceuticals and that would help you stay ahead with latest innovations evolving in various parts of the world.
This edition has innovations screened from Belgium-Sporobiotics to Japan- Nichi Glucans.
This edition has a transcript of an interview between our Editor and Chief – Sheldon Baker and business of interest to us.
All future editions will also be unique in the information being brought to you that can certainly impact your business progressively.
Trust me, these magazines are worth documenting as each edition will set standards for next edition.
If you have something interesting to share to the nutraceutical world then do write to us at hello@nutrifytoday.com
Delayed release capsules with probiotics, prebiotics, enzymes and activated c...Divyanshu Raval
Probiotics, prebiotics, enzymes, and activated charcoal are formulated in delayed release capsules to target delivery and promote beneficial effects in the host. Probiotics must survive the acidic gastric environment and reach the intestines in adequate amounts to confer health benefits. The delayed release capsules are designed to protect the ingredients from stomach acidity and delay release until the intestines, preserving potency. Clinical studies show the capsules successfully target delivery by delaying release and protecting ingredients from acid in the stomach.
This document reviews strategies for producing probiotic non-dairy products and evaluating their health benefits. It discusses using fruit juices as a matrix for probiotic microorganisms and describes studies processing probiotic mango and mixed berry juices. Major factors affecting probiotic survival in juices are addressed, along with strategies like fortification with prebiotics, microencapsulation, adaptation, and continuous fermentation technologies. The viability of probiotics in food products depends on maintaining concentrations of 106-107 CFU/g at consumption.
Advancement in research for improving the ambient temperature stability of a ...Arup Nag
An overview of my research in a Centre of Research Excellence in New Zealand to develop novel technology which successfuly enabled probiotic strains remain stable for longer duration under ambient storage conditions.
Functional foods are foods that provide health benefits beyond basic nutrition. They include both unmodified whole foods like fruits and vegetables that contain beneficial compounds, as well as modified foods that have been fortified or enriched with additional nutrients. Examples of natural functional foods include blueberries, which contain antioxidants like anthocyanins that may reduce inflammation and cancer risk, and cacao beans, which are rich in polyphenols that have antioxidant effects. Other functional foods include omega-3 enriched eggs, oats containing beta-glucan, fatty fish with DHA/EPA, tomatoes containing lycopene, and nuts containing monounsaturated fatty acids and vitamin E. These components and foods have been shown to provide benefits like lowering cholesterol
The document discusses nutraceuticals and their health benefits. It defines nutraceuticals as dietary supplements that provide health benefits. Some key points made in the document include:
- Nutraceuticals can help increase health, longevity, and avoid medical conditions by improving diet and lifestyle. They are perceived as more natural than traditional medicines.
- Examples of common nutraceuticals include probiotics, prebiotics, antioxidants, herbs, vitamins, and minerals.
- Specific nutraceuticals like carotenoids, fatty acids, flavonoids can provide benefits like reducing free radicals and heart disease risk.
- The nutraceutical market is large in countries like the US and Europe
Dr. San probiotic lozenges contain the probiotic strain Lactobacillus rhamnosus SD11, which can optimize the oral microbiome and significantly reduce tooth decay. The lozenges are an innovative oral health product meant to improve dental health in a non-invasive way. Clinical trials showed L. rhamnosus SD11 reduces levels of cavity-causing bacteria in subjects' mouths after consumption. The company believes these probiotic lozenges can significantly impact oral health and the dental industry.
Paper Presented-Soya Fortified YorghurtPrapti Patel
This document summarizes a research article about fortifying homemade yogurt with soy flour to increase its protein and iron content. The researchers produced soy-fortified yogurt by adding soy flour to plain yogurt and culturing it with probiotic bacteria. They then conducted a sensory evaluation of the product among students. The results showed that fortifying yogurt with soy flour in this way can successfully improve its nutritional profile by increasing protein and iron levels. This has benefits for food security, as probiotic functional foods could be encouraged, especially for malnutrition.
The global probiotics market is expected to reach $52.34 billion by 2020, with Asia Pacific being the largest and fastest growing market. India's probiotic market is small currently but projected to grow at a CAGR of 25% during 2014-2019. Dairy foods represent the largest segment of the functional food market, accounting for 65% of sales. Dairy provides an ideal vehicle for delivering probiotics due to its ability to protect probiotic bacteria through refrigeration and buffering stomach acid. However, the food matrix, manufacturing processes, and storage conditions can impact the viability, stability, and functionality of probiotic bacteria. Ensuring adequate viable cell counts of probiotics throughout a product's shelf life remains a key challenge
ABSTRACT- Fruits and vegetables are the important source in human life. It should be safe and consists of good shelf
life which can improve the level of consumption of fruits and vegetable among the society. The processing is such a great
parameter which analyses the quality of food. Today fruits and vegetables are susceptible to the growth of microorganism
which may be air borne, soil borne and water borne disease. Enzymes offer potential for many exciting applications for
the improvement of foods. There is still, however, a long way to go in realizing this potential. Economic factors i.e.
achievement of the optimum yields and efficient recovery of desired protein are the main deterrents in the use of enzymes.
Changing values in society with respect to recombinant DNA & protein engineering technologies and the growing need to
explore all alternative food sources may in time make enzyme applications more attractive to the food industry
Key-words- Enzyme, immobilization, Screening, Food spoilage, Enzymes, Bacterial contamination, Food poisoning,
Perishable foods
The use of modern biotechnology to modify food for human consumption is an undeniable source of unlimited possibilities. These types of technologies allow the development not only of the products themselves but also the optimization in their production process. Nutritionally enhanced crops are undoubtedly a solution to end with worldwide malnutrition as well as to ease some chronic diseases. Other foods, such as microorganisms or dietetic additives, may be a food source which provides nutritious, abundant and environmentally friendly products. Moreover, taking advantage of edible coating in order to preserve food, products can be supplemented with extra properties. This development may certainly be a solution to many society’s problems, but in order to do that, it has first to cope with the skepticism that it supposes.
This document provides an overview of Microba, a leading microbial genomics company that offers predictive diagnostics and therapeutics based on gut microbiome testing. Microba uses metagenomic sequencing to provide more accurate and detailed microbiome profiling than previous methods. Their modular platform includes at-home sample collection, online reporting of results with personalized recommendations, and telehealth support services. The document highlights several applications of Microba's platform and discusses partnerships with other companies to deliver customized microbiome testing solutions internationally.
Genetic modification and gene editing techniques allow scientists to alter genes in crops and livestock in order to produce desirable traits more rapidly than traditional breeding methods. While genetically modified foods may have benefits like increased nutrient levels or resistance to pests and drought, there are also concerns about potential health risks and environmental impacts. Gene editing provides a targeted way to modify genes and could help address some concerns about genetic modification, but there are still legal and social issues surrounding new food technologies.
2018421019 bioencapsulation technologies for incorporating bioactive compone...Rezwana Nishat
This document discusses bioencapsulation technologies for incorporating bioactive components into functional foods. It describes how there are several techniques for encapsulating functional ingredients, such as spray drying, fluid bed coating, and emulsification. These techniques involve coating droplets of active ingredients with carrier polymers. The document then discusses polymers used for encapsulation, different encapsulation methods like nanoencapsulation, and examples of encapsulating ingredients like fish oils, vitamins, and antioxidants. It concludes by discussing how nutrigenomics and biotechnology will influence the future of functional foods.
DECLARATION OF HELSINKI - History and principlesanaghabharat01
This SlideShare presentation provides a comprehensive overview of the Declaration of Helsinki, a foundational document outlining ethical guidelines for conducting medical research involving human subjects.
low birth weight presentation. Low birth weight (LBW) infant is defined as the one whose birth weight is less than 2500g irrespective of their gestational age. Premature birth and low birth weight(LBW) is still a serious problem in newborn. Causing high morbidity and mortality rate worldwide. The nursing care provide to low birth weight babies is crucial in promoting their overall health and development. Through careful assessment, diagnosis,, planning, and evaluation plays a vital role in ensuring these vulnerable infants receive the specialize care they need. In India every third of the infant weight less than 2500g.
Birth period, socioeconomical status, nutritional and intrauterine environment are the factors influencing low birth weight
Osteoporosis - Definition , Evaluation and Management .pdfJim Jacob Roy
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdfrightmanforbloodline
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
Test bank for karp s cell and molecular biology 9th edition by gerald karp.pdf
5-hydroxytryptamine or 5-HT or Serotonin is a neurotransmitter that serves a range of roles in the human body. It is sometimes referred to as the happy chemical since it promotes overall well-being and happiness.
It is mostly found in the brain, intestines, and blood platelets.
5-HT is utilised to transport messages between nerve cells, is known to be involved in smooth muscle contraction, and adds to overall well-being and pleasure, among other benefits. 5-HT regulates the body's sleep-wake cycles and internal clock by acting as a precursor to melatonin.
It is hypothesised to regulate hunger, emotions, motor, cognitive, and autonomic processes.
The skin is the largest organ and its health plays a vital role among the other sense organs. The skin concerns like acne breakout, psoriasis, or anything similar along the lines, finding a qualified and experienced dermatologist becomes paramount.
Co-Chairs, Val J. Lowe, MD, and Cyrus A. Raji, MD, PhD, prepared useful Practice Aids pertaining to Alzheimer’s disease for this CME/AAPA activity titled “Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neuroradiology in Diagnosis and Treatment.” For the full presentation, downloadable Practice Aids, and complete CME/AAPA information, and to apply for credit, please visit us at https://bit.ly/3PvVY25. CME/AAPA credit will be available until June 28, 2025.
10 Benefits an EPCR Software should Bring to EMS Organizations Traumasoft LLC
The benefits of an ePCR solution should extend to the whole EMS organization, not just certain groups of people or certain departments. It should provide more than just a form for entering and a database for storing information. It should also include a workflow of how information is communicated, used and stored across the entire organization.
Kosmoderma Academy, a leading institution in the field of dermatology and aesthetics, offers comprehensive courses in cosmetology and trichology. Our specialized courses on PRP (Hair), DR+Growth Factor, GFC, and Qr678 are designed to equip practitioners with advanced skills and knowledge to excel in hair restoration and growth treatments.
June 2024 Oncology Cartoons By Dr Kanhu Charan Patro
B plan
1. Venture Name
:
GLYCOPHARMA.
Category
:
Life Sciences,
Health Care.
Project stage
:
Prototype testing.
Underway.
Grant
:
BIG, Department Of
Biotechnology.
Contact Person:
A.R.Muralidharan
Incubatee, Indian Institute of Crop Processing Technology
Tanjore.
E-mail – naratturmurali@rediffmail.com
Mobile – 8754483776, 9445666317.
2. World’s only glycosylated Banana juice with Pharmaconutritive potential using a novel Glycotechnology tool.
Prevention based health care product for gut dysfunction.
Executive Summary
We have produced a novel nutraceutical from one variety of indigenous banana
using enzyme Glycotechnology, a new field of Biotechnology. The fruit has been
modified at molecular level to make available two therapeutic forms namely
Bioactives and Glycocores to be used in preventing intestinal infections and
inflammation. This Bioactive state is unavailable in a normal banana fruit. The
Bioactives deactivates four enteropathogens namely Shigella Flexineri, E.Coli,
Salmonella spp, Klebsiella pneumonia and cleanse intestine from infections. The
unique Glycocores (sugar cores) strengthen the intestinal walls by specific
complex sugar bonds.
This is a preventive based Health Care product and safeguards the intestine
against plethora of gut disorders like Ulcerative Colitis, Crohn’s disease, Celiac
disease, infections and inflammation. Presently there is no product targeted at
preventing intestinal infection and inflammation as against the secondary Gut
health care products addressing flatulence, acidity, indigestion etc. Our product
draws a direct correlation between consumption and disease prevention. The
startup is presently undergoing rigorous prototype testing and semi-commercial
run. We have been successful in initiating initial marketing contacts. The product
will carve its own market owing to non availability of similar product in the
respective category. The product has a global market and it can sustain
competition owing to the exclusive IPR rights obtained from the invention. The
startup capital requirement including the working capital comes to around 100
lakhs and the breakeven will be achieved in a year.
3. BUSINESS CONCEPT
Prevention based health care
Banana pulp/ fruit
Enzymatic Glycosylation
Banana juice
Food meets
Biomolecular modification – Value addition
Pharma
Complex functional beverage/nutraceutical
Presently no technology for making banana juice. Ours is the only product *.
Product and process patentable
Value addition of the juice to mucosal health protectant – a highly complex
neutraceutical to treat gut dysfunction, only one of its kind **.
Final product contains Bioactives and Glycocores.
Bio actives inactivate enteropathogenic organisms through compound mediated
innate immunity, acting as a powerful anti inflammatory factor.
Glycocores complement in strengthening the damaged intestinal lining.
Scientific evidence available for FDA, USA, endorsement under “Qualified
claims“ category ***.
Organising for “Authorised claims” from FDA‟s centre for biologics evaluation
-----------------------------------------------------------------------------------------------------------------------------* Bananas aren’t the easiest thing to put in a bottle.’- Mr. Dave Bober of Daily Juice
Products, America’s # 1 selling family of non-alcoholic frozen blended cocktail mixes, juices and
new products.
* According to Nuclear Agriculture and Biotechnology Division, Baba Atomic Research
Center (BARC) – unlike other fruits, juice cannot be extracted from banana by any simple means
such as crushing, grinding or squeezing. If an appropriate technology is developed to extract juice
from banana, a highly marketable product could be produced. They have developed a product
called Banana nectar which is only 30-40% banana juice unlike our technology (100% banana
juice).
4. ** Prof. Bruce Watkins, Functional foods, Purdue University, on the role of mucosal
protectants – “we are not as developed in this area as pertains to creating functional foods that deliver
health protectants. So we need research to further describe, characterize and discover the roles of these
health protectants.”
th
**
Prof Martin Wikham during an international event on functional food 29-30 Sep 2011 on
Innovative Health – Promoting Food – Gastro – Intestinal performance expressed key considerations - To
deliver success in the Gut health market, industry and consumers demand innovation. How can science
deliver this innovation? – Leatherheed Food Research.
*** “Qualified claims” endorsement from FDA requires less scientific evidence whereas “Authorised
claims” requires very strong scientific evidence.
TECHNOLOGY STEPS
Glycoprotein (ethnic banana)
Removing N-glycans
Deglycosylated Banana 1
Removing less specific O- linkages
Deglycosylated Banana 2
Removing enzyme specific O-linked glycans
Unmet gut health
care need
Banana juice
(With Bioactives and Glycocores)
We have engineered a novel nutraceutical beverage from ethnic banana using enzyme
technology from its pulp, enabling bioactives and complex sugar cores. The former
deactivates four enteropathogens preventing intestinal infections. The latter prevents
5. inflammation by the formation of specific complex sugar bonds, unique to the intestine.
We have utilized the unique signaling channels of this banana, whose cycle lasts for
less than 12 hrs post harvest stage
Description of technology
In scientific terms, eating a raw banana vis a vis banana juice has a marked difference
in the quality of available bio active components for our health. Moreover bananas are
difficult to convert in to juice owing to internal shielding effect. Our banana juice
processing invention (the only one of its kind) using novel glycobiology principles is a
breakthrough not only in banana juice processing but also engineering bio active
banana state. The principle involves the use of a novel enzyme with distinct specificity
to act on the reducing end of sugar bonds (attached to select protein terminal) to
produce natural juice. The enzyme used here is a novel one whose specificity for bond
breaking is unmatched except with a recently discovered metabolic enzyme. Even the
cloned metabolic enzymes have not been up to the mark.
Premise for the innovation
1. The complex carbohydrates of this ethnic banana match with that of the complex
carbohydrates present in the intestinal layer. This banana is highly specific for OGalNAc sugars. The intestine is extensively and more so exclusively packed on the
surface with the above specific complex sugars. This complex sugar coats are truncated
or reduced (short) in diseased conditions.
2. Plants undergo extensive glycosylation especially during stress and periods of
infection. A novel glycosylating enzyme in this pathway has been isolated and used in
the molecular modification of this ethnic banana. There is no enzyme presently which
can be used with this specificity, to modify the substrate.
This extent of glycosylation that we have brought about is unique and patentable. This
level of glycosylation will be difficult to achieve even with presently available process
namely hydrazinolysis and enzyme digestion (Ref: sigma glyco files). The bio active
6. component has shown activity with four enteropathogenic organisms displaying multi
glycosylation sites and will be effective to immune regulate the intestine for effective gut
defence. Then there are carefully carved glycocores to strengthen the complex sugar
ratios in intestinal layer.
The technology requires some crucial studies to highlight its therapeutic role in a larger
perspective. This will help us to organize ourselves for the much needed scientific
evidence towards clinching the „Authorized claims‟ status from the CBER ( center for
biologics evaluation and research), FDA. This will have a phenomenal impact in
marketing our product. Already we have scientific evidence to obtain the „Qualified
claims‟ status from the FDA. The „Authorized claims‟ status solicits a high degree of
scientific evidence as against the‟Qualified claims‟ status.
Benefits / Solution for the problem area
1. More than 3-5 bn people are affected with intestinal infections every year and in US
alone, it is more than 300 mn. Acute secretory diarrhea causes approximately 8,00,000
child deaths each year especially in developing and under developed countries.
Average cost of treatment is US $ 6256/patient.
More than 4mn people are affected with intestinal inflammation (1mn Americans) every
year on a global basis. Total health care cost is US$ 140 bn and economic impact
evaluated at US$ 6.3 bn annually.
Despite advancement in Medical Technology, procedures are expensive and are
partially effective. They do not address healing injuries and infection relapses. The ORS
(Oral rehydration therapy), a simple sugar and salt solution with zinc supplement and
electrolytes don‟t appear to work.
Our product is to be used in the prevention of intestinal disorders like Ulcerative
Colitis,
Crohn‟s disease, Celiac disease, enteropathogenic infections, inflammations
and related gut dysfunction. This product aims at lowering the economic burden of huge
health care costs of individuals through Preventive based health care treatment.
According to „NIH-2004 report‟, the healthcare costs of digestive disorders were
7. staggering $97.8 bn on direct medical costs and $44 bn on indirect costs in US alone
and are increasing.
2. This technology provides a breakthrough in the post harvest fruit processing sector.
As much as 40% of India‟s banana crop is lost to wastage which equals 10.5 million
thus, more than the total crop in Philippines.
There is an imperative need for new technology in the banana processing sector to
boost the economy. Lack of technology in banana fruit juice processing is a severe
constraint on its global trade. More over transportation costs of banana are expensive
as their refrigeration requires special provisions to improve their shelf life.
Raw Banana and Banana juice (Deglycosylated)
Raw banana is nutritious while the Banana juice is Pharmaco nutritive. The innovative
product has all the nutritional contents of banana as specified by WHO standards as
well as the unique components made bio available for preventing a disease.
Enzymatic digestion of banana
Stage I
Stage II
Stage III
8. Antibacterial activity of Bioactives with enteropathogens
Klebsiella Pneumonia
Shigella Flexineri
E.Coli
Salmonella
Market Analysis
Global market for Gut health nutraceuticals is US $ 60bn annually - 10% of
global health and wellness industry.
India‟s Digestive market Rs. 15.1bn in 2010, to grow by 66% in 2015 .
Competitors
Host of pharma companies and Health & Wellness products manufacturing firms
including Nestle, BASF nutrition, Abott Nutrition, Danone etc.
9. Product Positioning
Functional foods / beverages
Digestive health ingredients
1. prebiotics
2. probiotics
3. enzymes
4. protectants (our product)
Competitive advantage:
In the first year of successful commercial run, we plan to comply conditions and
research trials laid down by FDA for its approval. We already have sufficient evidence to
obtain the lesser valued „qualified claim‟ status endorsed by FDA of USA. Our claim for
preventive health care prospects of the products is materially different from lesser
claims as envisaged by our competitors‟ namely aiding digestion, good for heart, upset
stomach etc. We will organize and propose our technical inputs to get the ” Authorized
claims “status from FDA to have a phenomenal impact in marketing. However it is
interesting to note that there are no players who have been in the foray of producing
complex functional foods for gut/intestinal related problems including high level players
like Nestle, Danone, Yakult, Beneo etc. Again prebiotics and probiotics products
available in the market, although healthy, have not been specific in their functional
target. They have also been hit hard by the new regulatory process and have been
rejected due to insufficient characterization of approved gut health ingredients. Since
our digestive system is highly complex with intervening multiple biochemical signaling
pathways, the design of a complex nutraceutical and its non availability in the present
juncture adds value to our product.
10. Competitive Analysis
OUR PRODUCT
COMPETITORS
First Mucosal Health Protectant
No advanced Nutraceutical available Nestle Health Science
Product for primary gut disorder
secondary gut disorders. eg. Flatulence,
indigestion, acidity etc.
Scientific evidence already for “Qualified Hit hard by regulatory authorities
claims” from FDA, seeking for “ Authorised
claim” status.
Market- Growth rate and trends
Due to exceptional growth of the Indian economy and higher purchasing power parity
(PPP) of the consumers in the last decade, consumers are moving towards specific
functional foods. Although this is a new concept in our country and the market is still in
infancy, the demand for functional foods would continue to increase due to their specific
health benefits and Government‟s plan to invest $ 21.5 billion in food processing
industry in next five years. Industry analysts such as Frost & Sullivan and Netscribes
(India) Pvt. Ltd. also predict a continued growth of the sector in the future. Apart from
this, functional foods can be an opportunity for economic growth of our country as India
is endowed with rich biodiversity and traditional knowledge of the health effects of
certain indigenous plant species. According to the George Morris centre for the 20052010 review period, the digestive sector alone in the functional food category has been
valued as US$63.2bn for 32 markets combined.
11. Apart from the functional food sector, the natural health products category which
includes 100% fresh juices is also growing at a rapid pace. As our product cuts across
both the segments the start up is all set to have a niche market. Global imports of fresh
bananas have followed a long-term upward trend, reaching 16.3mmt in 2009. In the
near future, a number of large banana producers (notably India, and possibly Brazil,
which together grow almost double the volume of bananas currently traded worldwide)
could emerge as major banana exporters(source-Index mundi.com) . Banana juice thus
has a huge potential and will open up the market in a big way. The major impediment in
increasing banana global trade has been the lack of technology in juice processing and
our breakthrough technology will create waves in global banana trade.
Marketing
We have begun talks with „Nutrasorb‟ a nutraceutical company at New Jersey. The
company is backed by reputed R & D scientists Dr.llya Raskin, Professor, Rutgers state
university of New Jersey and Dr. Mary Ann Lila, Director, Plants for Human Health
Institute, North Carolina State University. The company will help us in obtaining the
required “claims” status from FDA for our nutraceutical beverage. Also they will leverage
on their marketing network for selling our products.
We are also opening another channel through Boots centre for innovation. Our major
targets are Walgreen and Alliance boots in US and UK respectively which comprises of
around 8000 outlets. We are about to initiate talks with Boots Center of Innovation
before which we are working on the presentation of technical details and specifically
addressing the functionality of the product. On successful screening we will have
access to their international outlets. The product can also be sold in our brand name.
In India we are looking for an exclusive pharma marketing company to market our
product. The Indian Pharmacy retail outlets are also taking new shapes and will focus
on Health & Wellness products. The retail chains through which we plan to sell our
product include:
12.
Apollo Pharmacy retail chain – 230 outlets.
Health & Glow – 65 operational stores.
Religare Wellness – pan India world class retail network of health stores –1000.
Med plus – 800 pharmacy stores.
Himalaya Health care
Trust Chemists & Druggists – 80 stores.
Zydus wellness – A cadila group.
Reliance Wellness.
Global Healthline – pharmacy retail chain with international presence.
Hetero pharmacy – A Indian pahrma company with 2000 crores as revenue.
We plan to market our product through an exclusive pharma marketing driven company.
The firm has a strong field force of 250 medical representatives who will highlight the
product to 65,000 doctors to generate prescription and sell the product. The company
has a dealer distribution network of 3, 00,000 chemist stores.
We are also meeting potential customers through Bio-partnering meets. A nutraceutical
company, Oriental yeast co Ltd, has evinced interest in our product and we are meeting
them in Bombay at Cphi‟2013, a pharma sourcing event during December.
Business System Description
The prototype has already been developed. We are incubating at The Indian Institute
of Crop Processing Technology, Tanjore. Rigorous testing of prototype is on the
anvil. The optimum recovery of Bioactive elements along with quality control is being
assessed. We are scaling up the production volume from 1ltr to 10 ltrs and then to 100
ltrs per batch production. The final produce is a freeze dried powder with active forms.
We plan to obtain certification from the Food Safety and Standards Authority of India
(FSSAI), an autonomous statutory body, under the aegis of the health ministry,
13. which ensures food safety, regulate foods for special purposes as well as nutritional
uses. Raw materials are available in plenty in the region.
MILESTONE
2013
Nov
1.
2.
Dec
2014
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Rigorous Prototype Testing
Assays Health care
3.
Qualified Claims
4.
5.
6.
7.
Authorised Claims
Patenting
Test market 1
Test market 2
8.
Commercial run
Financial Analysis
The budget estimate for the startup has been pegged at Rs 100 lakhs, with equipment
and machinery alone costing Rs 80 lakhs. As we are planning to utilize the incubation
facilities of IICPT, Tanjore, the rental costs would be calculated in the working capital.
Our average cost of sales will take in to account the cost of enzyme, raw materials and
elements involved in the processing module including the packaging costs. In
determining the costs of inputs, we have inflated the costs by 15% to 20% to take care
of the market risks. The working capital requirement for 3 months period is Rs 20 lakhs.
The sales price of 100 gms of banana mucosal health protectant has been fixed at
Rs.5000 after buffering sales commission as high as 30% which can be reduced by
10% or more in the market place. This price fixation is nevertheless less compared
to those fixed for functional food products globally, often with less scientific
evidence than our product to be used in preventive health care.
16. Exit strategy
We have plans to strengthen this start up in to a fully fledged R&D driven Agri Food
Biotechnology Company. Our future plans include the development of processing
technologies for other varieties of banana, jackfruit and other tropical fruits to exploit the
versatility of tropical fruits.
TEAM
A.R.Muralidharan, B.Sc
Incubatee, IICPT, Biotechnology Ignition Grant, DBT
More than 12 years of experience in Food Biotechnology industry. First to introduce
high temperature Button mushroom isolates in south India along with a researcher at
Horticultural research institute, wellesborne. Owner of this invention along with another
team member.
A.Pallavi, M.Sc Biochemistry
Glycobiology researcher
7 years of experience in Biotechnology
A.M.Sripriya, Bsc. Biochem, PGDMLT
Glycobiology researcher
8 years experience in Biochemistry
.